Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers
- Prestige Wealth Inc. (NASDAQ:PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial public offering of 1 million shares of common stock at a price of $5 per share.
- Gorilla Technology Group Inc. (NASDAQ:GRRR) jumped 68.9% to $3.52 after the company signed a $270 million contract with the Government of Egypt to implement a Smart Government Security Convergence solution.
- Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares climbed 64.8% to $0.3576 after dropping over 5% on Thursday.
- Castle Biosciences, Inc. (NASDAQ:CSTL) shares surged 42.2% to $18.89. Castle Biosciences will present new DecisionDx-SCC and DecisionDx-melanoma data at the American Head & Neck Society's International Conference on head and neck cancer.
- SCWorx Corp. (NASDAQ:WORX) gained 28.8% to $0.3780.
- Near Intelligence, Inc. (NASDAQ:NIR) climbed 27.6% to $1.5182. Benchmark initiated coverage on Near Intelligence with a Speculative Buy rating and announced a price target of $3.
- CareDx, Inc (NASDAQ:CDNA) climbed 19.7% to $10.04.
- The Beachbody Company, Inc. (NYSE:BODY) gained 17.2% to $0.3749 after dropping around 24% on Thursday.
- NuZee, Inc. (NASDAQ:NUZE) climbed 15.6% to $10.57 after the company announced it entered into a five-year global licensing agreement with Stone Brewing.
- TMC the metals company Inc. (NASDAQ:TMC) rose 15.5% to $2.3450.
- Society Pass Incorporated (NASDAQ:SOPA) jumped 14.7% to $0.5389. Society Pass subsidiary, NextGen Retail, will acquire Indonesia's PT Inetindo Infocom for $1.85 million.
- ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) climbed 14.5% to $0.2766 after the company announced the European Patent Office granted a patent covering the company's Phase 2a-ready Cholesterol Efflux Mediator VAR 200 for use in diabetic nephropathy/diabetic kidney disease.
- T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 14.2% to $0.0948. T2 Biosystems recently announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into its common stock and Series B convertible preferred stock.
- Applied Optoelectronics, Inc. (NASDAQ:AAOI) jumped 12.4% to $7.32.
- Cenntro Electric Group Limited (NASDAQ:CENN) gained 12.4% to $0.3672.
- Paramount Group, Inc. (NYSE:PGRE) climbed 11.4% to $4.8250.
- TOP Financial Group Limited (NASDAQ:TOP) rose 11.3% to $7.42 after dropping 9% on Thursday. TOP Financial Group recently said fiscal year 2023 revenue increased 24% to $9.7 million, up from $7.8 million in the previous year.
- Iris Energy Limited (NASDAQ:IREN) climbed 11.6% to $6.80.
- Rivian Automotive, Inc. (NASDAQ:RIVN) rose 11.2% to $24.05 after Wedbush raised its price target on the stock from $25 to $30.
- Greenidge Generation Holdings Inc. (NASDAQ:GREE) gained 10.6% to $4.28.
- Riot Platforms, Inc. (NASDAQ:RIOT) jumped 10.3% to $14.93. The company announced June 2023 production and operations updates.
- COMPASS Pathways plc (NASDAQ:CMPS) rose 9.6% to $10.24.
- TG Therapeutics, Inc. (NASDAQ:TGTX) gained 9.2% to $25.18.
- WW International, Inc. (NASDAQ:WW) rose 6.3% to $8.16.
Losers
- EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares dropped 21.4% to $18.04 after gaining over 93% on Thursday.
- FOXO Technologies Inc. (NASDAQ:FOXO) fell 20.6% to $0.2485.
- Alpine Summit Energy Partners, Inc. (NASDAQ:ALPS) dropped 17.4% to $0.2399.
- PainReform Ltd. (NASDAQ:PRFX) fell 17.5% to $4.58. PainReform recently said its supplier of API has received a deficiency notice from the FDA related to its drug master file.
- ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) shares fell 13.5% to $2.49. ASLAN Pharmaceuticals recently said the eblasakimab 400mg Q4W dosing arm did not meet the primary or secondary endpoints with statistical significance.
- UTStarcom Holdings Corp. (NASDAQ:UTSI) dropped 12.5% to $3.16.
- NLS Pharmaceutics AG (NASDAQ:NLSP) fell 11.7% to $1.05. NLS Pharmaceutics recently announced that the FDA reviewed the full protocol for the NLS-1031 study and the Institutional Review Board approved the Phase 3 clinical trial protocol to evaluate Mazindol ER in patients with narcolepsy type 1.
- iMedia Brands, Inc. (NASDAQ:IMBI) fell 11.3% to $0.1198 after the company announced it received a delisting notice from Nasdaq following its Chapter 11 filing.
- authID Inc. (NASDAQ:AUID) dropped 10.5% to $0.76. authID announced 1-for-8 reverse stock split effective Monday July 10, 2023.
- Forian Inc. (NASDAQ:FORA) declined 10.5% to $2.13.
- Micromobility.com Inc. (NASDAQ:MCOM) fell 8.5% to $0.1181.
- Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) declined 8.3% to $0.6420. Powerbridge Technologies announced a strategic joint venture to drive digital financial innovation for agriculture and livestock industries.
- Kontoor Brands, Inc. (NYSE:KTB) fell 7.7% to $37.94.
- EHang Holdings Limited (NASDAQ:EH) dipped 7.1% to $15.00.
- Levi Strauss & Co. (NYSE:LEVI) dropped 5.1% to $13.50. Levi Strauss reported upbeat earnings for its second quarter, but lowered its annual profit outlook.
Now Read This: Tesla, Amazon And 2 Other Stocks Insiders Are Selling